Cravatex Stock Price Analysis and Quick Research Report. Is Cravatex an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Cravatex. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Cravatex has a PE ratio of 22.563149002802 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Cravatex has ROA of 20.4213% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Cravatex has a Current ratio of 12.3141.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Cravatex has a ROE of 24.9684%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Cravatex has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

• Sales growth: Cravatex has reported revenue growth of 156.3145% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Cravatex for the current financial year is -55.8185116453637%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Cravatex is Rs 12.5 and the yield is 2.8536%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Cravatex is Rs 19.4144. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Cravatex in Ticker for free. Also, one can get the intrinsic value of Cravatex by using Valuation Calculators, which are available with a Finology ONE subscription. 

Cravatex FAQs

Q1. What is Cravatex share price today?
Ans: The current share price of Cravatex is Rs 438.05.

Q2. What is the market capitalisation of Cravatex?
Ans: Cravatex has a market capitalisation of Rs 113.1991288 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Cravatex?
Ans: The PE ratio of Cravatex is 22.563149002802 and the P/B ratio of Cravatex is 5.15803814393052, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Cravatex share?
Ans: The 52-week high share price of Cravatex is Rs 619, and the 52-week low share price of Cravatex is Rs 310.05.

Q5. Does Cravatex pay dividends?
Ans: Currently, Cravatex pays dividends. Dividend yield of Cravatex is around 2.8536%.

Q6. What are the face value and book value of Cravatex shares?
Ans: The face value of Cravatex shares is Rs 10, while the book value per share of Cravatex is around Rs 84.9257. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Cravatex?
Ans: Cravatex has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Cravatex?
Ans: The ROE of Cravatex is 24.9684% and ROCE of Cravatex is 29.7987%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Cravatex a good buy for the long term?
Ans: The Cravatex long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Cravatex undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Cravatex appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Cravatex’s financials?
Ans: You can review Cravatex’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.